These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1571342)

  • 1. Successful withdrawal of corticosteroids in heart transplantation.
    Miller LW; Wolford T; McBride LR; Peigh P; Pennington DG
    J Heart Lung Transplant; 1992; 11(2 Pt 2):431-4. PubMed ID: 1571342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of steroid withdrawal in pediatric renal allograft recipients (a 5-year follow-up).
    Roberti I; Reisman L; Lieberman KV; Burrows L
    Clin Transplant; 1994 Aug; 8(4):405-8. PubMed ID: 7949548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial success of steroid weaning late after heart transplantation.
    Kobashigawa JA; Stevenson LW; Brownfield ED; Moriguchi JD; Kawata N; Fandrich R; Drinkwater DC; Laks H
    J Heart Lung Transplant; 1992; 11(2 Pt 2):428-30. PubMed ID: 1571341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis.
    Trouillot TE; Shrestha R; Kam I; Wachs M; Everson GT
    Liver Transpl Surg; 1999 Sep; 5(5):375-80. PubMed ID: 10477838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question.
    Keogh A; Macdonald P; Harvison A; Richens D; Mundy J; Spratt P
    J Heart Lung Transplant; 1992; 11(2 Pt 2):421-7. PubMed ID: 1571340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.
    Taylor DO; Bristow MR; O'Connell JB; Price GD; Hammond EH; Doty DB; Karwande SV; Gay WA; Jones KW; Lappé D; Renlund DG
    J Heart Lung Transplant; 1996 Oct; 15(10):1039-46. PubMed ID: 8913922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
    Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
    J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid withdrawal in the pediatric heart transplant recipient initially treated with triple immunosuppression.
    Canter CE; Moorhead S; Saffitz JE; Huddleston CB; Spray TL
    J Heart Lung Transplant; 1994; 13(1 Pt 1):74-9; discussion 79-80. PubMed ID: 8167131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid-free maintenance immunotherapy: Minneapolis Heart Institute experience.
    Pritzker MR; Lake KD; Reutzel TJ; Hoffman FM; Jorgensen CR; Pederson W; Emery RW
    J Heart Lung Transplant; 1992; 11(2 Pt 2):415-20. PubMed ID: 1571339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid withdrawal in kidney transplant recipients: is it a safe option?
    Sanfey H; Haussman G; Isaacs I; Ishitani M; Lobo P; McCullough C; Pruett T
    Clin Transplant; 1997 Oct; 11(5 Pt 2):500-4. PubMed ID: 9361950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
    Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
    J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized controlled trial of total immunosuppression withdrawal in liver transplant recipients: role of ursodeoxycholic acid.
    Assy N; Adams PC; Myers P; Simon V; Minuk GY; Wall W; Ghent CN
    Transplantation; 2007 Jun; 83(12):1571-6. PubMed ID: 17589339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of steroid withdrawal in pediatric renal transplant patients with suspected steroid toxicity.
    Klaus G; Jeck N; Konrad M; Förster B; Soergel M
    Clin Nephrol; 2001 Dec; 56(6):S37-42. PubMed ID: 11770812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation.
    Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL
    J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data.
    Hamiwka LA; Burns A; Bell L
    Pediatr Transplant; 2006 May; 10(3):337-44. PubMed ID: 16677358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary immunosuppression regimen of rapid steroid withdrawal after living related liver transplantation: a single-center experience.
    Toyoki Y; Hakamada K; Narumi S; Totsuka E; Nara M; Ono H; Ishizawa Y; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2279-81. PubMed ID: 15561218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-drug immunosuppression for heart transplantation in infants and children.
    Brown JW; Turrentine MW; Kesler KA; Mahomed Y; Darragh R; Evans K; Thompson L; Caldwell R
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S265-74. PubMed ID: 8312346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid withdrawal in lung transplant recipients.
    Borro JM; Solé A; De la Torre M; Pastor A; Tarazona V
    Transplant Proc; 2005 Nov; 37(9):3991-3. PubMed ID: 16386606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
    Sandborn WJ; Hay JE; Porayko MK; Gores GJ; Steers JL; Krom RA; Wiesner RH
    Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.